Company Harborside Inc. Canadian Securities Exchange

Company Harborside Inc. Canadian Securities Exchange

HBOR

CA53567E1034

Pharmaceuticals

Equities

HBOR

CA53567E1034

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Shareholders

Company contact information

Sector

Sales per Business

Sector Alternative Medicine

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Shareholders

Company contact information

Sector

Sales per Business

Sector Alternative Medicine

Delayed Canadian Securities Exchange Other stock markets 16:18:46 05/10/2021 BST			5-day change	1st Jan Change
0.96 ^CAD	-4.00%		-7.41%	-48.98%

04-16	StateHouse Holdings Brief: Said Overnight Felicia Snyder Appointed as Independent Chair of the Board, Effective April 14, 2024; Also Anticipated Delays in Filing its Audited Annual Financial Statements	MT
04-16	StateHouse Announces Board Changes	CI

Harborside Inc. is a Canada-based cannabis company. The Company operates 11 dispensaries covering Northern and Southern California and one in Oregon, as well as a manufacturing facility in Oakland, California, distribution facilities in San Jose and Los Angeles, California and an integrated cultivation/production facility in Salinas, California. The Company holds cannabis licenses for retail, distribution, cultivation, nursery and manufacturing. The Company has a portfolio of approximately four owned brands, including Sublime, Key, Harborside and Loudpack.

CAD in Million	2021	Weight	2022	Weight	Delta
Cannabis and Cannabis Products 100.0 %	14	18.3 %	141	100.0 %	+915.85%

CAD in Million	2021	Weight	2022	Weight	Delta
United States 100.0 %	76	100.0 %	141	100.0 %	+86.40%

Managers	Title	Age	Since
Edward Schmults CEO	Chief Executive Officer	61	28/02/22
Kavi Bhai DFI	Director of Finance/CFO	-	05/06/22
Ahmer Iqbal COO	Chief Operating Officer	-	18/07/21
John Nichols CMP	Compliance Officer	-	-
Robert Bacchi CTO	Chief Tech/Sci/R&D Officer	-	04/04/22
Angela Pih SAM	Sales & Marketing	-	05/06/22
Alexis Mora SAM	Sales & Marketing	-	-
Willie Frank Senn PRN	Corporate Officer/Principal	-	28/02/22
Conrad Gregory LAW	General Counsel	-	-

Members of the board	Title	Age	Since
Edward Schmults CEO	Chief Executive Officer	61	28/02/22
Felicia Snyder CHM	Chairman	-	25/05/22
James Scott BRD	Director/Board Member	-	30/06/22
Tiffany Liff BRD	Director/Board Member	-	04/04/22

Name	Equities	%	Valuation
Entourage Effect Capital LLC 11.15 %	28,503,533	11.15 %	1 M $
Edward Schmults 0.1847 %	472,072	0.1847 %	17 939 $
Andy Sturner 0.0880 %	225,000	0.0880 %	8 550 $
Marc Ravner 0.0744 %	190,202	0.0744 %	7 228 $
Arrow Capital Management, Inc. 0.0685 %	175,000	0.0685 %	6 650 $
James Scott 0.0626 %	160,000	0.0626 %	6 080 $
Felicia Snyder 0.0527 %	134,750	0.0527 %	5 121 $
Gofen & Glossberg LLC 0.0333 %	85,000	0.0333 %	3 230 $
Moloney Securities Asset Management LLC 0.005869 %	15,000	0.005869 %	570 $
J. Roy Pottle 0.000000 %	0	0.000000 %	- $

StateHouse Holdings, Inc.

1295 West Morena Bouliverd

92110, San Diego

http://www.statehouseholdings.com

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+45.15%	6.38B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-14.00%	4.59B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+9.54%	3.39B
TASLY PHARMACEUTICAL GROUP CO., LTD	-8.99%	3.2B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+50.03%	2B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-6.97%	1.7B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-0.31%	1.65B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+50.00%	1.55B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-10.61%	1.58B

Alternative Medicine

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Alternative Medicine